Repaglinide M1 metabolite

SL-11550

Repaglinide M1 metabolite, >98%

IUPAC Name : (S)-4-(2-((1-(2-Aminophenyl)-3-methylbutyl)amino)-2-oxoethyl)-2-ethoxybenzoic acid

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : This is a metabolite of Repaglinide, which is a potassium channel blocker, that lowers blood glucose by stimulating the release of insulin from the pancreas, used to treat for the type II diabetes.

References : Hansen A. M. et al.: Br. J. Pharmacol., 144(4), 551-557, 2005; Okada M. et al.: Biochem J. 375(Pt 1), 87-97, 2003; Laghmich A. et al.: Eur. J. Pharmacol., 348(2-3), 265-270, 1998; Ladriere L. et al. Eur J Pharmacol., 335(2-3), 227-234, 1997.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.